APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Painkillers

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global OTC Painkillers Market Analysis and Forecast 2026-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchOTC Painkillers Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Painkillers Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal OTC Painkillers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Painkillers Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Painkillers Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global OTC Painkillers market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for OTC Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for OTC Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for OTC Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for OTC Painkillers is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of OTC Painkillers include Genetic Pharmaceuticals, Sanofi, Johnson & Johnson, Novartis, Prestige Brands, Pfizer, GSK, Dupont Pharmaceuticals and Bausch + Lomb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for OTC Painkillers, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of OTC Painkillers, also provides the revenue of main regions and countries. Of the upcoming market potential for OTC Painkillers, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the OTC Painkillers revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global OTC Painkillers market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for OTC Painkillers revenue, projected growth trends, production technology, application and end-user industry.

OTC Painkillers Segment by Company

Genetic Pharmaceuticals

Sanofi

Johnson & Johnson

Novartis

Prestige Brands

Pfizer

GSK

Dupont Pharmaceuticals

Bausch + Lomb

Bayer

AstraZeneca

Alvogen

Westwood-Squibb Pharmaceuticals

Reckitt Benckiser

Morton Pharmaceuticals

OTC Painkillers Segment by Type

NSAIDs

Acetaminophen

Others

OTC Painkillers Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

OTC Painkillers Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Painkillers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Painkillers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Painkillers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of OTC Painkillers in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of OTC Painkillers company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Painkillers revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Painkillers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. NSAIDs Major Player Table 3. Acetaminophen Major Player Table 4. Others Major Player Table 5. Global OTC Painkillers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Pharmacies Major Player Table 7. Online Pharmacies Major Player Table 8. Retail Pharmacies Major Player Table 9. OTC Painkillers Industry Trends Table 10. OTC Painkillers Industry Drivers Table 11. OTC Painkillers Industry Opportunities and Challenges Table 12. OTC Painkillers Industry Restraints Table 13. Global OTC Painkillers Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global OTC Painkillers Market Size by Region (2021-2026) & (US$ Million) Table 15. Global OTC Painkillers Market Share by Region (2021-2026) Table 16. Global OTC Painkillers Market Size by Region (2027-2032) & (US$ Million) Table 17. Global OTC Painkillers Market Share by Region (2027-2032) Table 18. Global OTC Painkillers Revenue by Players (US$ Million) & (2021-2026) Table 19. Global OTC Painkillers Revenue Market Share by Players (2021-2026) Table 20. Global OTC Painkillers Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global OTC Painkillers Key Players Headquarters & Area Served Table 22. Global OTC Painkillers Players, Product Type & Application Table 23. Global OTC Painkillers Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global OTC Painkillers by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global OTC Painkillers Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global OTC Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 28. Global OTC Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 29. Global OTC Painkillers Revenue Market Share by Type (2021-2026) Table 30. Global OTC Painkillers Revenue Market Share by Type (2027-2032) Table 31. Global OTC Painkillers Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global OTC Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 33. Global OTC Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 34. Global OTC Painkillers Revenue Market Share by Application (2021-2026) Table 35. Global OTC Painkillers Revenue Market Share by Application (2027-2032) Table 36. Genetic Pharmaceuticals Company Information Table 37. Genetic Pharmaceuticals Business Overview Table 38. Genetic Pharmaceuticals OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Genetic Pharmaceuticals OTC Painkillers Product Portfolio Table 40. Genetic Pharmaceuticals Recent Development Table 41. Sanofi Company Information Table 42. Sanofi Business Overview Table 43. Sanofi OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Sanofi OTC Painkillers Product Portfolio Table 45. Sanofi Recent Development Table 46. Johnson & Johnson Company Information Table 47. Johnson & Johnson Business Overview Table 48. Johnson & Johnson OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Johnson & Johnson OTC Painkillers Product Portfolio Table 50. Johnson & Johnson Recent Development Table 51. Novartis Company Information Table 52. Novartis Business Overview Table 53. Novartis OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Novartis OTC Painkillers Product Portfolio Table 55. Novartis Recent Development Table 56. Prestige Brands Company Information Table 57. Prestige Brands Business Overview Table 58. Prestige Brands OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Prestige Brands OTC Painkillers Product Portfolio Table 60. Prestige Brands Recent Development Table 61. Pfizer Company Information Table 62. Pfizer Business Overview Table 63. Pfizer OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Pfizer OTC Painkillers Product Portfolio Table 65. Pfizer Recent Development Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. GSK OTC Painkillers Product Portfolio Table 70. GSK Recent Development Table 71. Dupont Pharmaceuticals Company Information Table 72. Dupont Pharmaceuticals Business Overview Table 73. Dupont Pharmaceuticals OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Dupont Pharmaceuticals OTC Painkillers Product Portfolio Table 75. Dupont Pharmaceuticals Recent Development Table 76. Bausch + Lomb Company Information Table 77. Bausch + Lomb Business Overview Table 78. Bausch + Lomb OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Bausch + Lomb OTC Painkillers Product Portfolio Table 80. Bausch + Lomb Recent Development Table 81. Bayer Company Information Table 82. Bayer Business Overview Table 83. Bayer OTC Painkillers Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bayer OTC Painkillers Product Portfolio Table 85. Bayer Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca OTC Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. AstraZeneca OTC Painkillers Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Alvogen Company Information Table 92. Alvogen Business Overview Table 93. Alvogen OTC Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Alvogen OTC Painkillers Product Portfolio Table 95. Alvogen Recent Development Table 96. Westwood-Squibb Pharmaceuticals Company Information Table 97. Westwood-Squibb Pharmaceuticals Business Overview Table 98. Westwood-Squibb Pharmaceuticals OTC Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Westwood-Squibb Pharmaceuticals OTC Painkillers Product Portfolio Table 100. Westwood-Squibb Pharmaceuticals Recent Development Table 101. Reckitt Benckiser Company Information Table 102. Reckitt Benckiser Business Overview Table 103. Reckitt Benckiser OTC Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Reckitt Benckiser OTC Painkillers Product Portfolio Table 105. Reckitt Benckiser Recent Development Table 106. Morton Pharmaceuticals Company Information Table 107. Morton Pharmaceuticals Business Overview Table 108. Morton Pharmaceuticals OTC Painkillers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Morton Pharmaceuticals OTC Painkillers Product Portfolio Table 110. Morton Pharmaceuticals Recent Development Table 111. North America OTC Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 112. North America OTC Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 113. North America OTC Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 114. North America OTC Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 115. North America OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America OTC Painkillers Revenue by Country (2021-2026) & (US$ Million) Table 117. North America OTC Painkillers Revenue by Country (US$ Million) & (2027-2032) Table 118. Europe OTC Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe OTC Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe OTC Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe OTC Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe OTC Painkillers Revenue by Country (2021-2026) & (US$ Million) Table 124. Europe OTC Painkillers Revenue by Country (US$ Million) & (2027-2032) Table 125. China OTC Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 126. China OTC Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 127. China OTC Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 128. China OTC Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia OTC Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 130. Asia OTC Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 131. Asia OTC Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 132. Asia OTC Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 133. Asia OTC Painkillers Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Asia OTC Painkillers Revenue by Region (US$ Million) & (2021-2026) Table 135. Asia OTC Painkillers Revenue by Region (US$ Million) & (2027-2032) Table 136. SAMEA OTC Painkillers Revenue by Type (2021-2026) & (US$ Million) Table 137. SAMEA OTC Painkillers Revenue by Type (2027-2032) & (US$ Million) Table 138. SAMEA OTC Painkillers Revenue by Application (2021-2026) & (US$ Million) Table 139. SAMEA OTC Painkillers Revenue by Application (2027-2032) & (US$ Million) Table 140. SAMEA OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. SAMEA OTC Painkillers Revenue by Country (2021-2026) & (US$ Million) Table 142. SAMEA OTC Painkillers Revenue by Country (US$ Million) & (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. OTC Painkillers Image Figure 2. Global OTC Painkillers Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global OTC Painkillers Market Size Share 2021 VS 2025 VS 2032 Figure 4. NSAIDs Image Figure 5. Acetaminophen Image Figure 6. Others Image Figure 7. Global OTC Painkillers Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global OTC Painkillers Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Pharmacies Image Figure 10. Online Pharmacies Image Figure 11. Retail Pharmacies Image Figure 12. Global OTC Painkillers Market Size (US$ Million) & (2021-2032) Figure 13. Global OTC Painkillers Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global OTC Painkillers Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global OTC Painkillers Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global OTC Painkillers Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global OTC Painkillers Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global OTC Painkillers Revenue Market Share by Type (2021-2032) Figure 20. Global OTC Painkillers Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global OTC Painkillers Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global OTC Painkillers Revenue Market Share by Application (2021-2032) Figure 23. North America OTC Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America OTC Painkillers Revenue Share by Type (2021-2032) Figure 25. North America OTC Painkillers Revenue Share by Application (2021-2032) Figure 26. North America OTC Painkillers Revenue Share by Country (2021-2032) Figure 27. United States OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe OTC Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe OTC Painkillers Revenue Share by Type (2021-2032) Figure 32. Europe OTC Painkillers Revenue Share by Application (2021-2032) Figure 33. Europe OTC Painkillers Revenue Share by Country (2021-2032) Figure 34. Germany OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China OTC Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China OTC Painkillers Revenue Share by Type (2021-2032) Figure 44. China OTC Painkillers Revenue Share by Application (2021-2032) Figure 45. Asia OTC Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia OTC Painkillers Revenue Share by Type (2021-2032) Figure 47. Asia OTC Painkillers Revenue Share by Application (2021-2032) Figure 48. Asia OTC Painkillers Revenue Share by Region (2021-2032) Figure 49. Japan OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA OTC Painkillers Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA OTC Painkillers Revenue Share by Type (2021-2032) Figure 57. SAMEA OTC Painkillers Revenue Share by Application (2021-2032) Figure 58. SAMEA OTC Painkillers Revenue Share by Country (2021-2032) Figure 59. Brazil OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt OTC Painkillers Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • NSAIDs
  • Acetaminophen
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Genetic Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Prestige Brands
  • Pfizer
  • GSK
  • Dupont Pharmaceuticals
  • Bausch + Lomb
  • Bayer
  • AstraZeneca
  • Alvogen
  • Westwood-Squibb Pharmaceuticals
  • Reckitt Benckiser
  • Morton Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 OTC Painkillers Market by Type
  3. 1.2.1 Global OTC Painkillers Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 NSAIDs
  5. 1.2.3 Acetaminophen
  6. 1.2.4 Others
  7. 1.3 OTC Painkillers Market by Application
  8. 1.3.1 Global OTC Painkillers Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital Pharmacies
  10. 1.3.3 Online Pharmacies
  11. 1.3.4 Retail Pharmacies
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 OTC Painkillers Market Dynamics
  1. 2.1 OTC Painkillers Industry Trends
  2. 2.2 OTC Painkillers Industry Drivers
  3. 2.3 OTC Painkillers Industry Opportunities and Challenges
  4. 2.4 OTC Painkillers Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global OTC Painkillers Market Perspective (2021-2032)
  2. 3.2 Global OTC Painkillers Growth Trends by Region
  3. 3.2.1 Global OTC Painkillers Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global OTC Painkillers Market Size by Region (2021-2026)
  5. 3.2.3 Global OTC Painkillers Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global OTC Painkillers Revenue by Players
  2. 4.1.1 Global OTC Painkillers Revenue by Players (2021-2026)
  3. 4.1.2 Global OTC Painkillers Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global OTC Painkillers Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global OTC Painkillers Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global OTC Painkillers Key Players Headquarters & Area Served
  7. 4.4 Global OTC Painkillers Players, Product Type & Application
  8. 4.5 Global OTC Painkillers Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global OTC Painkillers Market CR5 and HHI
  11. 4.6.3 2025 OTC Painkillers Tier 1, Tier 2, and Tier 3
5 OTC Painkillers Market Size by Type
  1. 5.1 Global OTC Painkillers Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Painkillers Revenue by Type (2021-2032)
  3. 5.3 Global OTC Painkillers Revenue Market Share by Type (2021-2032)
6 OTC Painkillers Market Size by Application
  1. 6.1 Global OTC Painkillers Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global OTC Painkillers Revenue by Application (2021-2032)
  3. 6.3 Global OTC Painkillers Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Genetic Pharmaceuticals
  2. 7.1.1 Genetic Pharmaceuticals Company Information
  3. 7.1.2 Genetic Pharmaceuticals Business Overview
  4. 7.1.3 Genetic Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Genetic Pharmaceuticals OTC Painkillers Product Portfolio
  6. 7.1.5 Genetic Pharmaceuticals Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi OTC Painkillers Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi OTC Painkillers Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Johnson & Johnson
  14. 7.3.1 Johnson & Johnson Company Information
  15. 7.3.2 Johnson & Johnson Business Overview
  16. 7.3.3 Johnson & Johnson OTC Painkillers Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Johnson & Johnson OTC Painkillers Product Portfolio
  18. 7.3.5 Johnson & Johnson Recent Developments
  19. 7.4 Novartis
  20. 7.4.1 Novartis Company Information
  21. 7.4.2 Novartis Business Overview
  22. 7.4.3 Novartis OTC Painkillers Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Novartis OTC Painkillers Product Portfolio
  24. 7.4.5 Novartis Recent Developments
  25. 7.5 Prestige Brands
  26. 7.5.1 Prestige Brands Company Information
  27. 7.5.2 Prestige Brands Business Overview
  28. 7.5.3 Prestige Brands OTC Painkillers Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Prestige Brands OTC Painkillers Product Portfolio
  30. 7.5.5 Prestige Brands Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer OTC Painkillers Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer OTC Painkillers Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GSK
  38. 7.7.1 GSK Company Information
  39. 7.7.2 GSK Business Overview
  40. 7.7.3 GSK OTC Painkillers Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GSK OTC Painkillers Product Portfolio
  42. 7.7.5 GSK Recent Developments
  43. 7.8 Dupont Pharmaceuticals
  44. 7.8.1 Dupont Pharmaceuticals Company Information
  45. 7.8.2 Dupont Pharmaceuticals Business Overview
  46. 7.8.3 Dupont Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Dupont Pharmaceuticals OTC Painkillers Product Portfolio
  48. 7.8.5 Dupont Pharmaceuticals Recent Developments
  49. 7.9 Bausch + Lomb
  50. 7.9.1 Bausch + Lomb Company Information
  51. 7.9.2 Bausch + Lomb Business Overview
  52. 7.9.3 Bausch + Lomb OTC Painkillers Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Bausch + Lomb OTC Painkillers Product Portfolio
  54. 7.9.5 Bausch + Lomb Recent Developments
  55. 7.10 Bayer
  56. 7.10.1 Bayer Company Information
  57. 7.10.2 Bayer Business Overview
  58. 7.10.3 Bayer OTC Painkillers Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bayer OTC Painkillers Product Portfolio
  60. 7.10.5 Bayer Recent Developments
  61. 7.11 AstraZeneca
  62. 7.11.1 AstraZeneca Company Information
  63. 7.11.2 AstraZeneca Business Overview
  64. 7.11.3 AstraZeneca OTC Painkillers Revenue and Gross Margin (2021-2026)
  65. 7.11.4 AstraZeneca OTC Painkillers Product Portfolio
  66. 7.11.5 AstraZeneca Recent Developments
  67. 7.12 Alvogen
  68. 7.12.1 Alvogen Company Information
  69. 7.12.2 Alvogen Business Overview
  70. 7.12.3 Alvogen OTC Painkillers Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Alvogen OTC Painkillers Product Portfolio
  72. 7.12.5 Alvogen Recent Developments
  73. 7.13 Westwood-Squibb Pharmaceuticals
  74. 7.13.1 Westwood-Squibb Pharmaceuticals Company Information
  75. 7.13.2 Westwood-Squibb Pharmaceuticals Business Overview
  76. 7.13.3 Westwood-Squibb Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Westwood-Squibb Pharmaceuticals OTC Painkillers Product Portfolio
  78. 7.13.5 Westwood-Squibb Pharmaceuticals Recent Developments
  79. 7.14 Reckitt Benckiser
  80. 7.14.1 Reckitt Benckiser Company Information
  81. 7.14.2 Reckitt Benckiser Business Overview
  82. 7.14.3 Reckitt Benckiser OTC Painkillers Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Reckitt Benckiser OTC Painkillers Product Portfolio
  84. 7.14.5 Reckitt Benckiser Recent Developments
  85. 7.15 Morton Pharmaceuticals
  86. 7.15.1 Morton Pharmaceuticals Company Information
  87. 7.15.2 Morton Pharmaceuticals Business Overview
  88. 7.15.3 Morton Pharmaceuticals OTC Painkillers Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Morton Pharmaceuticals OTC Painkillers Product Portfolio
  90. 7.15.5 Morton Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America OTC Painkillers Revenue (2021-2032)
  2. 8.2 North America OTC Painkillers Revenue by Type (2021-2032)
  3. 8.2.1 North America OTC Painkillers Revenue by Type (2021-2026)
  4. 8.2.2 North America OTC Painkillers Revenue by Type (2027-2032)
  5. 8.3 North America OTC Painkillers Revenue Share by Type (2021-2032)
  6. 8.4 North America OTC Painkillers Revenue by Application (2021-2032)
  7. 8.4.1 North America OTC Painkillers Revenue by Application (2021-2026)
  8. 8.4.2 North America OTC Painkillers Revenue by Application (2027-2032)
  9. 8.5 North America OTC Painkillers Revenue Share by Application (2021-2032)
  10. 8.6 North America OTC Painkillers Revenue by Country
  11. 8.6.1 North America OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America OTC Painkillers Revenue by Country (2021-2026)
  13. 8.6.3 North America OTC Painkillers Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe OTC Painkillers Revenue (2021-2032)
  2. 9.2 Europe OTC Painkillers Revenue by Type (2021-2032)
  3. 9.2.1 Europe OTC Painkillers Revenue by Type (2021-2026)
  4. 9.2.2 Europe OTC Painkillers Revenue by Type (2027-2032)
  5. 9.3 Europe OTC Painkillers Revenue Share by Type (2021-2032)
  6. 9.4 Europe OTC Painkillers Revenue by Application (2021-2032)
  7. 9.4.1 Europe OTC Painkillers Revenue by Application (2021-2026)
  8. 9.4.2 Europe OTC Painkillers Revenue by Application (2027-2032)
  9. 9.5 Europe OTC Painkillers Revenue Share by Application (2021-2032)
  10. 9.6 Europe OTC Painkillers Revenue by Country
  11. 9.6.1 Europe OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe OTC Painkillers Revenue by Country (2021-2026)
  13. 9.6.3 Europe OTC Painkillers Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China OTC Painkillers Revenue (2021-2032)
  2. 10.2 China OTC Painkillers Revenue by Type (2021-2032)
  3. 10.2.1 China OTC Painkillers Revenue by Type (2021-2026)
  4. 10.2.2 China OTC Painkillers Revenue by Type (2027-2032)
  5. 10.3 China OTC Painkillers Revenue Share by Type (2021-2032)
  6. 10.4 China OTC Painkillers Revenue by Application (2021-2032)
  7. 10.4.1 China OTC Painkillers Revenue by Application (2021-2026)
  8. 10.4.2 China OTC Painkillers Revenue by Application (2027-2032)
  9. 10.5 China OTC Painkillers Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia OTC Painkillers Revenue (2021-2032)
  2. 11.2 Asia OTC Painkillers Revenue by Type (2021-2032)
  3. 11.2.1 Asia OTC Painkillers Revenue by Type (2021-2026)
  4. 11.2.2 Asia OTC Painkillers Revenue by Type (2027-2032)
  5. 11.3 Asia OTC Painkillers Revenue Share by Type (2021-2032)
  6. 11.4 Asia OTC Painkillers Revenue by Application (2021-2032)
  7. 11.4.1 Asia OTC Painkillers Revenue by Application (2021-2026)
  8. 11.4.2 Asia OTC Painkillers Revenue by Application (2027-2032)
  9. 11.5 Asia OTC Painkillers Revenue Share by Application (2021-2032)
  10. 11.6 Asia OTC Painkillers Revenue by Country
  11. 11.6.1 Asia OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia OTC Painkillers Revenue by Country (2021-2026)
  13. 11.6.3 Asia OTC Painkillers Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA OTC Painkillers Revenue (2021-2032)
  2. 12.2 SAMEA OTC Painkillers Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA OTC Painkillers Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA OTC Painkillers Revenue by Type (2027-2032)
  5. 12.3 SAMEA OTC Painkillers Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA OTC Painkillers Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA OTC Painkillers Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA OTC Painkillers Revenue by Application (2027-2032)
  9. 12.5 SAMEA OTC Painkillers Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA OTC Painkillers Revenue by Country
  11. 12.6.1 SAMEA OTC Painkillers Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA OTC Painkillers Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA OTC Painkillers Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst